Avidity Biosciences(RNA) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

RNA Avidity Biosciences

Watchlist

29.520
-2.080-6.58%

Close Mar 31 16:00 ET

29.520
0.0000.00%

Post 16:36 ET

3.55BMarket Cap-10.21P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Avidity Biosciences Inc: Plan to Present Topline Data From Fortitude Dose Escalation Cohorts in Q2 2025
ReutersMar 31 09:01 ET
Express News | Avidity Biosciences Inc: Regulatory Alignment on Global Phase 3 Del-Brax Trial Design and Study Initiation Anticipated in Q2 2025
ReutersMar 31 09:01 ET
Express News | Avidity Biosciences Completes Enrollment in Biomarker Cohort in Phase 1/2 Fortitude™ Trial for Delpacibart Braxlosiran (Del-Brax) in People Living With Facioscapulohumeral Muscular Dystrophy
ReutersMar 31 09:01 ET
Insider Sale: Chief Medical Officer of $RNA Sells 9,578 Shares
Quiver QuantitativeMar 21 18:46 ET
Express News | Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ReutersMar 21 16:05 ET
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR NewswireMar 21 16:05 ET

Comments

Teddy123

9 hours ago

Avidity Biosciences Completes Enrollment in Biomarker Cohort in Phase 1/2 FORTITUDE™ Trial for Delpacibart Braxlosiran (del-brax) in People Living with Facioscapulohumeral Muscular Dystrophy

$Avidity Biosciences (RNA.US)$
Major Breakthrough: Avidity's Muscular Dystrophy Drug Achieves Unprecedented Disease Control in Clinical Trial

Teddy123

Mar 17 20:53

Avidity Biosciences Announces Positive Topline Del-zota Data Demonstrating Consistent, Statistically Significant Improvements in Dystrophin, Exon Skipping and Creatine Kinase in People Living with Duc

$Avidity Biosciences (RNA.US)$
Avidity's DMD Drug Achieves 40% Exon Skipping Success, Transforming Duchenne Treatment

Awal

Dec 12, 2024 23:52

$Avidity Biosciences (RNA.US)$ Am I missing something? This stock has dropped so much over the last month and I don’t see any bad news 🧐

Stock_Drift

Sep 24, 2024 04:13

$Avidity Biosciences (RNA.US)$

Moomoo Recap US

Jun 13, 2024 04:24

Columns Third Day of Index Records, FOMC Said One Cut Coming | Wall Street Today

The FOMC left rates the same Wednesday afternoon, pointing to about one cut this year. The market was genuinely higher with record index prices.
As a recap just past 10:20 AM EST, the $S&P 500 Index (.SPX.US)$ was climbing past a record by 1.23%, the $Dow Jones Industrial Average (.DJI.US)$ climbed 0.57%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 1.43%. The indexes gapped higher Wednesday morning, the dow jumping 500...

Crucial Wednesday: Inflation report and FOMC rate decision

RNA Avidity Biosciences

Trade Overview

Capital Trend

News

Comments

Market Insights